Get started
Author

Jieya Wu

Prospective: Evolution of Chinese Medicine to Treat COVID-19 Patients in China
2021 · Jieya Wu, Baoguo Sun, et al. · Frontiers in Pharmacology · 17
PDF
Improvement of Early Death in Acute Promyelocytic Leukemia: A Population-Based Analysis
2022 · Guangda Li, Jieya Wu, et al. · Clinical Lymphoma Myeloma & Leukemia · 14
Global, Regional and National Burden of Leukemia, 1990-2021: Analysis of Data from the Global Burden of Disease Study 2021
2024 · Zhangjun Yun, Yayue Zhang, et al. · Blood · 11
Chromosome 5q deletion drives evolution of aneuploidy in myeloid neoplasms with complex karyotype
2026 · J. Philip Creamer, Suhita Ray, et al. · Blood · 3
The transition from myelodysplastic neoplasm to secondary acute myeloid leukemia is revealed by molecular analysis, while functional drug screening demonstrates novel sensitivity patterns with clinical implication
2025 · Jieya Wu, Guangrong Qin, et al. · Blood
Combined CXCR-4 Inhibition with Novel Agent GPC-100 (burixafor) and Beta 2 Adrenergic Receptor Blockade Enhances Cytarabine Response for Acute Myeloid Leukemia Blasts on Stroma
2024 · Yueming Tang, Adam Braun, et al. · Blood
PDF
Efficacy of Yisui granule on myelodysplastic syndromes in SKM-1 mouse xenograft model through suppressing Wnt/β-catenin signaling pathway.
2024 · W U Jieya, Hou Li, et al. · PubMed
PDF
Research on Different Compound Combinations of Realgar-Indigo Naturalis Formula to Reverse APL Arsenic Resistance By Regulating Autophagy through mTOR Pathway
2023 · Ruibai Li, Yiming Pan, et al. · Blood
PDF
Abstract 2092: Effects of Yi Sui Granules, an herbal medicine, on MDS/AML: Similar to decitabine or other mechanisms
2021 · Jing Wang, Chong Gao, et al. · Cancer Research
Works count: 9
Citation count: 44
H-index: 3
I10-index: 3
Year
Topic
Type